These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 35081736)

  • 1. Biomarkers in Kawasaki disease.
    Huerta Barberá S; Sánchez Andrés A
    Biomark Med; 2022 Jan; ():. PubMed ID: 35081736
    [No Abstract]   [Full Text] [Related]  

  • 2. The serum concentration of soluble interleukin-2 receptor in patients with Kawasaki disease.
    Teraura H; Kotani K; Minami T; Takeshima T; Shimooki O; Kajii E
    Ann Clin Biochem; 2017 Mar; 54(2):209-213. PubMed ID: 28081636
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Change in plasma N-terminal pro-brain natriuretic peptide in children with Kawasaki disease and its value in clinical practice].
    Zhang QY; Du JB; Chen YH; Li WZ
    Zhonghua Er Ke Za Zhi; 2006 Dec; 44(12):886-90. PubMed ID: 17254452
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The mucocutaneous lymph node syndrome (Kawasaki syndrome). A case with gallbladder hydrops and coronary artery aneurysm].
    Fritz ME; Giambonini S; Jenni R; D'Apuzzo V
    Schweiz Med Wochenschr; 1981 Apr; 111(16):566-71. PubMed ID: 7233135
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Blood N-terminal Pro-brain Natriuretic Peptide and Interleukin-17 for Distinguishing Incomplete Kawasaki Disease from Infectious Diseases.
    Wu L; Chen Y; Zhong S; Li Y; Dai X; Di Y
    Indian Pediatr; 2015 Jun; 52(6):477-80. PubMed ID: 26121721
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Giant coronary aneurysms in infant with Kawasaki disease shock syndrome].
    García-Domínguez M; Riviera-Navarro D; Quibrera J; Pérez-Gaxiola G
    Rev Alerg Mex; 2020; 67(2):174-182. PubMed ID: 32892531
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Brain natriuretic peptide as a clinical screening tool for the diagnosis of Kawasaki disease.
    Jung JH; Hwang S; Jung JY; Park JW; Lee EJ; Lee HN; Kim JH; Kim DK; Kwak YH
    Medicine (Baltimore); 2023 Jul; 102(29):e34319. PubMed ID: 37478221
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of PCT, BNP and Inflammatory Factors in Children with Kawasaki Disease and Their Correlation with Coronary Artery Lesions.
    Feng H; Chai H; Li D; Shi C; Xu Y; Liu Y
    Altern Ther Health Med; 2024 Jan; 30(1):302-306. PubMed ID: 37820655
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Rupture of a coronary artery aneurysm in mucocutaneous lymph node syndrome (Kawasaki syndrome). Demonstration of the coronary aneurysms by 2-dimensional echocardiography].
    Lunkenheimer A; Mellin W; Pfefferkorn J; Löser H; Hilgenberg F
    Monatsschr Kinderheilkd; 1984 Dec; 132(12):909-12. PubMed ID: 6521749
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Successful Surgical Treatment of Coronary Aneurysm, Ascending Aortic Aneurysm, and Bicuspid Aorta for a Kawasaki Disease Patient.
    Borulu F; Koza Y; Erkut B
    Braz J Cardiovasc Surg; 2022 Oct; 37(5):784-787. PubMed ID: 35072408
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased Pentraxin 3 Levels Correlate With IVIG Responsiveness and Coronary Artery Aneurysm Formation in Kawasaki Disease.
    Kitoh T; Ohara T; Muto T; Okumura A; Baba R; Koizumi Y; Yamagishi Y; Mikamo H; Daigo K; Hamakubo T
    Front Immunol; 2021; 12():624802. PubMed ID: 33912155
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sudden death in an adolescent four years after recovery from mucocutaneous lymph node syndrome (Kawasaki disease).
    Quam JP; Edwards WD; Bambara JF; Luzier TL
    J Forensic Sci; 1986 Jul; 31(3):1135-41. PubMed ID: 3734732
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interleukin-6 is prone to be a candidate biomarker for predicting incomplete and IVIG nonresponsive Kawasaki disease rather than coronary artery aneurysm.
    Wu Y; Liu FF; Xu Y; Wang JJ; Samadli S; Wu YF; Liu HH; Chen WX; Luo HH; Zhang DD; Wei W; Hu P
    Clin Exp Med; 2019 May; 19(2):173-181. PubMed ID: 30617865
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Decreased serum Annexin A1 levels in Kawasaki disease with coronary artery aneurysm.
    Weng H; Peng Y; Pei Q; Jing F; Yang M; Yi Q
    Pediatr Res; 2021 Feb; 89(3):569-573. PubMed ID: 32316027
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Kawasaki disease (mucocutaneous lymph node syndrome). Description of a case (author's transl)].
    Borel B; Delavenne J; Mandard JC; Rousselot P; Elie H
    Sem Hop; 1980 Sep 8-15; 56(29-32):1297-300. PubMed ID: 6252620
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Kawasaki disease. Mucocutaneous lymph node syndrome or MCLS.
    Kawasaki T
    Acta Pathol Jpn; 1982; 32 Suppl 1():63-72. PubMed ID: 7187577
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A child case of
    Türe M; Akın A; Ertaş F; Akın Oğuz A
    Cardiol Young; 2021 Sep; 31(9):1542-1544. PubMed ID: 34412729
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acute febrile mucocutaneous lymph node syndrome (Kawasaki disease) in an adult.
    Takamoto T; Niwa A; Taniguchi K; Takeuchi J
    Clin Cardiol; 1982 Oct; 5(10):555-9. PubMed ID: 7172516
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Periodic fever syndromes: a patient diagnosed with recurrent Kawasaki disease.
    Turk S; Aydin D; Dogan E; Levent E; Kutukculer N
    Cardiol Young; 2020 Jul; 30(7):1009-1011. PubMed ID: 32524933
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence of coronary artery lesions on the initial echocardiogram in Kawasaki syndrome.
    Baer AZ; Rubin LG; Shapiro CA; Sood SK; Rajan S; Shapir Y; Romano A; Bierman FZ
    Arch Pediatr Adolesc Med; 2006 Jul; 160(7):686-90. PubMed ID: 16818833
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.